Sign in

James Nathan

@jamesnathanlab.bsky.social
665 followers 196 following 14 posts

Professor of Respiratory Medicine, University of Cambridge. Cellular mechanisms of oxygen sensing and metabolism. jamesnathanlab.co.uk

PostsRepliesMedia
Reposted by James Nathan
Helena Cocheme @cochemelab.bsky.social · 5h
✨Excited to share our latest paper in Aging Cell!✨ "Direct Pharmacological Activation of AMPK Extends Lifespan in Yeast, Worms and Flies" Thanks to all the collaborators who made this multi-organism study possible! 💊🪱🪰🐁⏳ #TeamScience #Drosophila #C.elegans #S.pombe #Ageing doi.org/10.1111/acel...
093
James Nathan @jamesnathanlab.bsky.social · 14/08/2026
Secure your place at Redox – The Good, The Bad and The Unexpected by the super earlybird deadline of 16 August to save £100! Featuring an international lineup of redox experts, a publishing panel, networking opportunities and more, browse the exciting programme so far 🧪 bit.ly/Redox-26
bit.ly
Redox – The Good, The Bad and The Unexpected
020
Reposted by James Nathan
Lorraine Reese @lorraine-reese.bsky.social · 12/08/2026
Secure your place at Redox – The Good, The Bad and The Unexpected by the super earlybird deadline of 16 August to save £100! Featuring an international lineup of redox experts, a publishing panel, networking opportunities and more, browse the exciting programme so far 🧪 bit.ly/Redox-26
Biochemical Society Scientific Meeting: Redox - The Good, The Bad and The Unexpected. Cambridge, UK. 16-18 November 2026. Super earlybird deadline 16 August. Abstract submissions now open. Includes image of smiling/laughing delegates in a Q&A session, and logos for the Biochemical Society and the event (image credit for event logo: Claudia Lennicke)
043
Reposted by James Nathan
Medicine at Cambridge @medcambridge.bsky.social · 10/06/2026
🔬 Respiratory Mechanisms of Disease (RC49887) Join @jamesnathanlab.bsky.social at #CITIID & @mitogene.bsky.social @mrc-mbu.bsky.social to investigate how mitochondrial dysfunction and mtDNA damage drive innate immune activation and contribute to COPD. 📅 Closing date: 5 July 2026 🔗 buff.ly/ujQDD8l
buff.ly
CG-TIC Postdoctoral Research Associate (Fixed Term)
We are seeking an experienced and motivated researcher to work on a Cambridge-GSK Translational Immunology Collaboration (CG-TIC) project. CG-TIC is a new translational initiative between Cambridge…
111
Reposted by James Nathan
Ram Chakrabarty @rpc3312.bsky.social · 21/05/2026
Very happy to share our new paper. Together with our wonderful collaborators, we found that L-2-HG, a metabolite often viewed as “toxic,” also has an essential physiological function in mice. www.nature.com/articles/s41...
nature.com
Mitochondrial l-2-hydroxyglutarate is a physiological signalling metabolite - Nature
l-2-Hydroxyglutarate is identified as a legitimate physiological signalling metabolite, and control of its levels is essential for postnatal growth and survival and correct renal development and funct...
32614
Reposted by James Nathan
Helena Cocheme @cochemelab.bsky.social · 15/05/2026
📍 Registration is now open for this #Redox #BiochemicalSociety Meeting! Excellent invited speakers, plus many slots for elevated talks from abstracts, including #ECRs 🫵 🌍 Cambridge, UK 🗓️ 16-18 Nov 2026 ⏳ Super early bird deadline: 16 Aug 2026 🌐 bit.ly/Redox-26 #BiochemEvent @biochemsoc.bsky.social
bit.ly
Redox – The Good, The Bad and The Unexpected
1105
James Nathan @jamesnathanlab.bsky.social · 25/03/2026
Congratulations Qing and Team on this exciting work www.jci.org/articles/vie...
jci.org
JCI - Genome-wide CRISPR screen identifies a cytokine–enhancer circuit driving HIF-2α activation in renal cancer
021
James Nathan @jamesnathanlab.bsky.social · 15/03/2026
Delighted to share the 'early access' version of our work examining genetic dependencies with VHL loss in ccRCC. Led by James Bertlin. Thanks to our wonderful collaborators Qing Zhang, Annie Speak, Tom Mitchell. Presenting the work today at #AACRkidney26 www.nature.com/articles/s41...
nature.com
VHL synthetic lethality screens uncover CBF-β as a negative regulator of STING - Nature Communications
Biallelic inactivation of the VHL tumour suppressor gene is a hallmark of Clear cell renal cell carcinoma (ccRCC). Here the authors perform genome-wide CRISPR/Cas9 screening to identify that loss of C...
040
Reposted by James Nathan
Waggoner Lab @labwaggoner.bsky.social · 13/03/2026
VHL synthetic lethality screens uncover CBF-β as a negative regulator of STING @natcomms.nature.com www.nature.com/articles/s41...
021
James Nathan @jamesnathanlab.bsky.social · 29/10/2025
Congratulations Manu, Sarah and Team! Enjoyed contributing to this work www.nature.com/articles/s41...
030
James Nathan @jamesnathanlab.bsky.social · 15/10/2025
Excited to share our first bioinformatics contribution! 🎉 Led by Niek Wit in collaboration with the van den Ameele lab @jellevda.bsky.social , we developed DamMapper damid-seq.readthedocs.io/en/latest/, a workflow for DamID-seq analysis, to map SET1B and HIF-1 chromatin occupancy. rdcu.be/eK2TS
rdcu.be
Mapping SET1B chromatin interactions with DamID using DamMapper, a comprehensive Snakemake workflow
093
Reposted by James Nathan
Emma Rawlins @labrawlins.bsky.social · 11/10/2025
Delighted that Ziqi Dong's PhD paper is out for all to read! Hypoxia is fundamental to normal development, and fascinating! Thanks to all of our co-authors including @jamesnathanlab.bsky.social @jellevda.bsky.social authors.elsevier.com/sd/article/S...
48227
Reposted by James Nathan
The Lister Institute of Preventive Medicine @thelisterinstitute.bsky.social · 22/09/2025
Congrats to #ListerFellow @jamesnathanlab.bsky.social and team on this tremendous paper in Science Advances exploring iron flux and metabolism. "Potentially explaining how some tumors evade antitumoral immunity."
031
James Nathan @jamesnathanlab.bsky.social · 18/09/2025
Happy to share latest work from the lab. Led by talented first author @awmartinelli.bsky.social. Mapping the genetic landscape of iron metabolism uncovers the SETD2 methyltransferase as a modulator of iron flux | Science Advances www.science.org/doi/10.1126/... Congratulations to all the team.
science.org
Mapping the genetic landscape of iron metabolism uncovers the SETD2 methyltransferase as a modulator of iron flux
Genetic screens using endogenous reporters map key modulators of cellular iron, including the transcriptional regulator SETD2.
0112
Reposted by James Nathan
The Lister Institute of Preventive Medicine @thelisterinstitute.bsky.social · 21/08/2025
"The Lister... spans an incredible breadth of science, giving access to world-leading experts in fields far from my own." @jamesnathanlab.bsky.social James and other #ListerFellows reflect on surprise discoveries and following their curiosity. #ListerPrize 👉 lister-institute.org.uk/curiosity-at...
031
Reposted by James Nathan
Medicine at Cambridge @medcambridge.bsky.social · 15/07/2025
🧬 New in @natchembio.nature.com : Researchers at #CITIID @cam.ac.uk & @ki.se identified #ABHD11 – a key enzyme that controls cellular energy production & immune response. Learn more: buff.ly/ZdOAdLe @hudsonwilco.bsky.social @jamesnathanlab.bsky.social
buff.ly
New study reveals key enzyme to control cellular energy production and immune function | Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID)
Uncovering ABHD11 as a key metabolic regulator could lead to new treatments for cancer, autoimmune diseases, and metabolic disorders.
021
James Nathan @jamesnathanlab.bsky.social · 15/07/2025
Delighted to share our latest work on ABHD11 as a novel deglutarylating enzyme, and its role in T cell metabolism @natchembio.nature.com rdcu.be/ewiYZ. Many congratulations to co-first authors Guine Grice, Eleanor Minogue and @hudsonwilco.bsky.social! Great team effort with Randall Johnson's lab.
rdcu.be
Lipoyl deglutarylation by ABHD11 regulates mitochondrial and T cell metabolism
Nature Chemical Biology - Glutarate rewires cell metabolism through conjugation to proteins or fatty acids, but how glutarylation is regulated is unclear. ABHD11 was identified as a...
1226
Reposted by James Nathan
Christian Frezza @frezzalab.bsky.social · 16/04/2025
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis www.nature.com/articles/s41...
nature.com
Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis - Nature
Nature - Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis
183
Reposted by James Nathan
Isha Jain @ishahjain.bsky.social · 17/02/2025
🚨 New paper alert! 🚨 Check out our latest work on HypoxyStat, a small-molecule therapy that increases oxygen-hemoglobin affinity and provides a practical form of hypoxia therapy. A great collaboration with Maze Therapeutics 🔗 Paper: doi.org/10.1016/j.ce... @cp-cell.bsky.social
doi.org
Redirecting
33012
James Nathan @jamesnathanlab.bsky.social · 27/11/2024
Having just joined bsky, thought it would be good to share our latest review and a couple of recent preprints from the group. First our review on the roles of deubiquitinating enzymes in hypoxia responses. portlandpress.com/biochemsoctr...
portlandpress.com
A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway
Hypoxia Inducible transcription Factors (HIFs) are central to the metazoan oxygen-sensing response. Under low oxygen conditions (hypoxia), HIFs are stabilised and govern an adaptive transcriptional pr...
2185
Reposted by James Nathan
Christian Frezza @frezzalab.bsky.social · 13/11/2024
People working on #cancermetabolism, #mitochondrialbiology, #metabolism, please reach out! Share this so I can follow who is here! I will share paper on cancer metabolism, but anything else related to mitochondria and metabolism.
media.tenor.com
a bald man in a blue suit is making a funny face and pointing at something .
ALT: a bald man in a blue suit is making a funny face and pointing at something .
68142